Ron McCord

1.8k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Ron McCord is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ron McCord has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Ron McCord's work include Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (6 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ron McCord is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (6 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ron McCord collaborates with scholars based in United States, Switzerland and United Kingdom. Ron McCord's co-authors include Elisabeth Berber, Katrin F. Chua, Adam S. Adler, Eriko Michishita, Tiara L.A. Kawahara, Meihong Lin, Lisa D. Boxer, Howard Y. Chang, Andrew K. Vershon and Carolyn Mickel and has published in prestigious journals such as Cell, Blood and Molecular and Cellular Biology.

In The Last Decade

Ron McCord

14 papers receiving 1.1k citations

Hit Papers

SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-De... 2009 2026 2014 2020 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
    2009 900 citations Tiara L.A. Kawahara, Eriko Michishita et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron McCord United States 10 551 501 293 260 179 14 1.1k
Zhu‐Qin Zhang China 16 437 0.8× 692 1.4× 377 1.3× 242 0.9× 90 0.5× 29 1.5k
Magali Joffraud Switzerland 14 332 0.6× 496 1.0× 313 1.1× 198 0.8× 217 1.2× 16 1.1k
Aline Huber France 9 478 0.9× 639 1.3× 292 1.0× 204 0.8× 675 3.8× 12 1.3k
Giovanna Sociali Italy 15 605 1.1× 293 0.6× 161 0.5× 253 1.0× 314 1.8× 18 1.1k
Hanzhi Luo United States 13 198 0.4× 979 2.0× 226 0.8× 245 0.9× 115 0.6× 18 1.5k
Caiyue Xu China 6 152 0.3× 544 1.1× 213 0.7× 378 1.5× 49 0.3× 7 978
Michael N. Davies United States 8 281 0.5× 507 1.0× 400 1.4× 219 0.8× 64 0.4× 9 934
M Witt Germany 12 143 0.3× 518 1.0× 85 0.3× 157 0.6× 406 2.3× 15 1.1k
Graeme J. Gowans United Kingdom 11 65 0.1× 1.0k 2.1× 199 0.7× 246 0.9× 79 0.4× 12 1.4k
Honggang Xiang China 10 160 0.3× 375 0.7× 80 0.3× 212 0.8× 79 0.4× 18 700

Countries citing papers authored by Ron McCord

Since Specialization
Citations

This map shows the geographic impact of Ron McCord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron McCord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron McCord more than expected).

Fields of papers citing papers by Ron McCord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron McCord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron McCord. The network helps show where Ron McCord may publish in the future.

Co-authorship network of co-authors of Ron McCord

This figure shows the co-authorship network connecting the top 25 collaborators of Ron McCord. A scholar is included among the top collaborators of Ron McCord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron McCord. Ron McCord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Morschhauser, Franck, Nilanjan Ghosh, Izidore S. Lossos, et al.. (2021). Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial. Blood Cancer Journal. 11(8). 147–147. 16 indexed citations
4.
Olszewski, Adam J., Abraham Avigdor, Sunil Babu, et al.. (2021). MOSUNETUZUMAB MONOTHERAPY IN ELDERLY/UNFIT PTS WITH FIRST‐LINE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): SAFETY AND EFFICACY REMAIN PROMISING WITH DURABLE COMPLETE RESPONSES. Hematological Oncology. 39(S2). 4 indexed citations
5.
Olszewski, Adam J., Abraham Avigdor, Sunil Babu, et al.. (2021). ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses. Clinical Lymphoma Myeloma & Leukemia. 21. S395–S396. 3 indexed citations
6.
Olszewski, Adam J., Abraham Avigdor, Sunil Babu, et al.. (2020). Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma. Blood. 136(Supplement 1). 43–45. 43 indexed citations
7.
Hernandez, Genevive, Ling‐Yuh Huw, Anton Belousov, et al.. (2019). Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma. Blood. 134(Supplement_1). 1585–1585. 11 indexed citations
8.
Xu, Pengpeng, Chun Sun, Xu Cao, et al.. (2018). Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies. EBioMedicine. 33. 94–104. 9 indexed citations
9.
Kawahara, Tiara L.A., Eriko Michishita, Adam S. Adler, et al.. (2009). SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span. Cell. 136(1). 62–74. 900 indexed citations breakdown →
10.
Michishita, Eriko, Adam S. Adler, Elisabeth Berber, et al.. (2009). SIRT6LinksHistoneH3Lysine9Deacetylation to NF-kB-Dependent Gene Expression and Organismal Life Span. 3 indexed citations
11.
McCord, Ron & Dominique Broccoli. (2008). Telomeric chromatin: Roles in aging, cancer and hereditary disease. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 647(1-2). 86–93. 9 indexed citations
12.
Mead, Janet E., et al.. (2007). Swapping the Gene-Specific and Regional Silencing Specificities of the Hst1 and Sir2 Histone Deacetylases. Molecular and Cellular Biology. 27(7). 2466–2475. 16 indexed citations
13.
McCord, Ron, et al.. (2003). Rfm1, a Novel Tethering Factor Required To Recruit the Hst1 Histone Deacetylase for Repression of Middle Sporulation Genes. Molecular and Cellular Biology. 23(6). 2009–2016. 66 indexed citations
14.
Zhong, Hualin, Ron McCord, & Andrew K. Vershon. (1999). Identification of Target Sites of the α2–Mcm1 Repressor Complex in the Yeast Genome. Genome Research. 9(11). 1040–1047. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhu‐Qin Zhang Breakdown of academic impact, for papers by Magali Joffraud Breakdown of academic impact, for papers by Aline Huber Breakdown of academic impact, for papers by Giovanna Sociali Breakdown of academic impact, for papers by Hanzhi Luo Breakdown of academic impact, for papers by Caiyue Xu Breakdown of academic impact, for papers by Michael N. Davies Breakdown of academic impact, for papers by M Witt Breakdown of academic impact, for papers by Graeme J. Gowans Breakdown of academic impact, for papers by Honggang Xiang
Rankless by CCL
2026